Fidelity Investments’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Fidelity Investments’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-334	Closed	-$12K	–	5668
2022 Q4	$12K	Sell	334 -5,060,913	-100%	-$127M	﹤0.01%	3946
2022 Q3	$76.2M	Buy	5,061,247 +882	+0%	+$14.3K	0.01%	1065
2022 Q2	$67.8M	Buy	5,060,365 +212,359	+4%	+$3.37M	0.01%	1125
2022 Q1	$93.4M	Buy	4,848,006 +1,998,411	+70%	+$41.5M	0.01%	1094
2021 Q4	$67.6M	Buy	2,849,595 +791,240	+38%	+$18.3M	0.01%	1291
2021 Q3	$41.2M	Buy	+2,058,355	New	+$44.2M	﹤0.01%	1498

Fidelity Investments's IMGO Position: Q1 2023 in Review

Fidelity Investments sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 334 shares — an estimated $12K sold.

Fidelity Investments first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $93.4M in Q1 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Fidelity Investments reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Fidelity Investments sold 334 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $12K.
Fidelity Investments first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Fidelity Investments's Imago BioSciences, Inc. Common stock position peaked at $93.4M in Q1 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.